
J&J to invest €100 million into Limerick manufacturing facilities creating 100 new jobs
pharmafile | May 16, 2019 | News story | Manufacturing and Production | Ireland, J&J, JJ, Limerick, medical technology, pharma
Healthcare conglomerate Johnson & Johnson has said it will be investing €100 million into the expansion of its Vision Care manufacturing facilities in Limerick. The expansion is expected to see the creation of 100 new jobs.
The Minister of State for Trade, Employment and Business, Deputy Pat Breen celebrated the investment in calling it a “huge vote of confidence” in Ireland’s mid-west.
“The expansion, supported by the Government through the IDA, reflects the commitment of the Government and its agencies to pursue balanced and sustainable regional development,” Minister Breen said.
“We believe that the new manufacturing roles being introduced in Limerick in 2019 will be foundational in helping us bring new, innovative contact lens products to our patients and customers around the world at an industry-leading pace,” Vision Care’s plant leader, John Lynch said.
The CEO of IDA Ireland – the agency responsible for attracting and retaining foreign investment – Martin Shanahan commented: “The approximately 100 jobs being added, along with those being created in the construction phase, will greatly benefit the economy of the Mid-West region.
“Having a company of this stature continue to expand its operations enhances Ireland’s global reputation as a Medical Technologies centre of excellence and demonstrates how global companies can successfully operate in regional locations. I wish John and his team continued success.”
Louis Goss
Related Content

Pharma sees climate disruption as growing supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …

Artificial hearts: a century of innovation
By Professor Brian J Ford Artificial heart technology has advanced through decades of scientific persistence, …






